Medical and Research Disclaimer

Medical and Research Disclaimer

The information on this website may reference compounded GLP-1 receptor agonists (e.g., Semaglutide) and GLP-1/GIP agonists (e.g., Tirzepatide), as well as various peptides—some FDA-approved for specific uses and many others not approved by the FDA. Please read carefully:

  1. Experimental and Investigational Nature
    • Compounded GLP-1 products and non-FDA-approved peptides are prepared or discussed solely under licensed healthcare provider direction for investigational or research purposes. Their safety, efficacy, and long-term risks have not been fully established.
    • Even when a peptide or GLP-1 agent has an FDA-approved counterpart, any compounded or off-label formulation mentioned here remains experimental unless explicitly approved for that exact use.
  2. No FDA Evaluation of Claims
    • Any statements about weight loss, metabolic health, longevity, performance enhancement, or other potential benefits have not been evaluated or endorsed by the Food and Drug Administration.
    • These statements do not diagnose, treat, cure, or prevent any disease.
  3. Context of Use
    • All non-FDA-approved compounds are intended strictly for laboratory research, educational purposes, or qualified physician directed investigational use. They are not for human consumption or unsupervised clinical application.
    • Compounded GLP-1 products are provided only within prescriber-guided, patient-specific clinical judgment and must not be used without proper medical oversight.
  4. Educational Purposes Only
    • Content on this site is offered for educational and informational purposes. It does not constitute medical advice or an endorsement of any compound or protocol. Always seek personalized guidance from a licensed healthcare professional before considering any investigational treatment.
  5. Risk of Misuse
    • Misuse or unsupervised use of any compounded GLP-1 or non-FDA-approved peptide is strictly prohibited and may carry significant health risks.
    • If you are a member of the general public, you should not make medical decisions based solely on content here; consult your healthcare provider for clinical evaluation.

By accessing or using information on this website, you acknowledge understanding that these references to compounded GLP-1 products and peptides are experimental or investigational, unapproved (or used off-label), and provided for educational purposes only. You agree not to interpret this content as an invitation to self-prescribe or to use any product without appropriate prescription, supervision, and monitoring by a qualified healthcare professional.

Medical Disclosure: CellGen Factor™ programs are available only through clinician evaluation and approval where appropriate.

Therapies and protocols discussed throughout this website have not been evaluated by the Food and Drug Administration unless specifically indicated otherwise. Results vary between individuals. No outcomes are guaranteed. This content is provided for informational and educational purposes only and should not be interpreted as medical advice or a guarantee of treatment eligibility.